Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

389
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
389
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

45.5K
VSEPR Theory for Determination of Electron Pair Geometries
45.5K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

222
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
222
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.4K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

574
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
574
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

518
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
518

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An External Patient Healthcare Index (EPHI) for Simulating Spatial Tendencies in Healthcare Seeking Behavior.

Frontiers in public health·2022
Same author

Characterization and Validation of ceRNA-Mediated Pathway-Pathway Crosstalk Networks Across Eight Major Cardiovascular Diseases.

Frontiers in cell and developmental biology·2022
Same author

Sonocatalytic degradation of ciprofloxacin using hydrogel beads of TiO<sub>2</sub> incorporated biochar and chitosan.

Journal of hazardous materials·2022
Same author

Degradation of biodegradable plastics by anaerobic digestion: Morphological, micro-structural changes and microbial community dynamics.

The Science of the total environment·2022
Same author

miR-203, fine-tunning neuroinflammation by juggling different components of NF-κB signaling.

Journal of neuroinflammation·2022
Same author

Mindfulness Moderates the Association Between Perceived Discrimination and Cyber Aggression Among Emerging Adults with Early Left-Behind Experience: A Longitudinal Study.

Psychology research and behavior management·2022
Same journal

Multimodal Contrastive Spatiotemporal Self-Organizing Neural Networks for In-Home Activity Learning of Mild Cognitive Impairment.

IEEE journal of biomedical and health informatics·2026
Same journal

Integrating Multi-View Residue Graph and Protein Language Model for Cell-Penetrating Peptide Prediction via Global-Local Graph Aggregation and Cross-Attentive Fusion.

IEEE journal of biomedical and health informatics·2026
Same journal

An Ultra-Lightweight Cross-scale Attention Mamba Network for Accurate Skin Lesion Segmentation.

IEEE journal of biomedical and health informatics·2026
Same journal

Explanation-Guided Reconstruction of Missing Clinical Features for Survival Prediction in Pancreatic Cancer.

IEEE journal of biomedical and health informatics·2026
Same journal

stDGCN: A dual-augmentation graph convolutional network for identifying spatial domains with attention mechanism.

IEEE journal of biomedical and health informatics·2026
Same journal

Patient-specific Biomechanical Investigation of Percutaneous Pulmonary Valves: Towards the Integration of Routinely Acquired Clinical Data and Fluid-structure Interaction Simulations.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.4K

An Explainable Molecular Token Estimation Method for Knowledge-Aware Drug-Drug Interaction Prediction.

Hui Yu, Chao Song, Jiahao Yuan

    IEEE Journal of Biomedical and Health Informatics
    |January 21, 2026
    PubMed
    Summary
    This summary is machine-generated.

    This study explores molecular representation learning (MRL) for drug-drug interaction (DDI) prediction. A new method, SimMotifPro, leverages motif tokens to improve model performance and understanding of molecular embeddings.

    More Related Videos

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.6K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.5K

    Related Experiment Videos

    Last Updated: Jan 23, 2026

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.4K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.6K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.5K

    Area of Science:

    • Computational chemistry
    • Machine learning
    • Bioinformatics

    Background:

    • Molecular representation learning (MRL) uses tokens like atoms and motifs to represent molecules for Graph Neural Networks (GNNs).
    • While GNNs with tokens show promise in drug-drug interaction (DDI) prediction, the impact of token choice on molecular embedding expressiveness is not well understood.

    Purpose of the Study:

    • To theoretically define MRL from a frequency domain perspective and analyze the influence of token count on model performance.
    • To propose SimMotifPro, an efficient motif-based method for DDI prediction that incorporates theoretical insights.

    Main Methods:

    • Developed an axiomatic definition of MRL from a frequency domain perspective to establish theoretical upper bounds for model convergence.
    • Proposed SimMotifPro, utilizing a DeeperGCN encoder, a motif-motif knowledge graph, and a Motif Ranker module for enhanced DDI prediction.

    Main Results:

    • Demonstrated that SimMotifPro aligns with the derived theoretical upper bounds, validating the proposed theory's general applicability.
    • Achieved state-of-the-art performance on multiple benchmarks for DDI prediction, showcasing the efficacy of the motif-based approach.

    Conclusions:

    • The number of tokens significantly impacts MRL model performance, with theoretical insights guiding the development of effective molecular embedding strategies.
    • SimMotifPro offers a robust and efficient solution for DDI prediction, highlighting the importance of motif-based representations and advanced GNN architectures.